Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

L Tonneijck, MM Smits, MHA Muskiet, T Hoekstra, MHH Kramer, Jan Danser, M Diamant, JA Joles, DH van Raalte

Research output: Contribution to journalArticleAcademicpeer-review

92 Citations (Scopus)
15 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1412-1421
Number of pages10
JournalDiabetologia
Volume59
Issue number7
DOIs
Publication statusPublished - 2016

Research programs

  • EMC COEUR-09
  • EMC COEUR-09-39-02

Cite this